BioCentury
ARTICLE | Company News

AquaBounty, Intrexon deal

November 5, 2012 8:00 AM UTC

Synthetic biology company Intrexon will acquire a 48% stake in AquaBounty from Linnaeus Capital Partners and its Tethys Ocean B.V. affiliate followed by a tender offer to acquire the rest of the compa...